Skip to content

Evaluation of the Effects of Different Doses of Ayahuasca on Intelligence and Verbal Memory in Healthy Volunteers

Caio César De Paula, Anna Beatriz Vicentini, Lorena Terene Lopes Guerra, Renan Massanobu Maekawa, José Augusto Silva Reis, Bianca Villanova, Caroline C. Gomes, Taini Bellucci, Giordano Novak Rossi, José Carlos Bouso, Jaime E. C. Hallak, Rafael Guimarães Dos Santos

Journal of Clinical Psychopharmacology October 19, 2026 DOI: 10.1097/jcp.0000000000002267 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Double-blind, randomized, placebo-controlled trial Peer reviewed
Sample size 28
Population Healthy volunteers
Intervention Ayahuasca
Dose 0.5, 1.0, or 1.5 mL/kg
Duration Single administration with assessments at baseline, 4 hours, and 21 days postadministration
Measures Wechsler Abbreviated Scale of Intelligence, Rey Auditory Verbal Learning Test
Topics Ayahuasca
Key findings A single ayahuasca dose produced no significant or persistent changes in standardized intelligence or verbal memory measures compared with placebo. The only group difference was better delayed recall at 4 hours in the placebo group than in the 0.5 mL/kg ayahuasca group; no effects remained at 21 days.

Abstract

Background: Observational studies with ritual ayahuasca users suggest that experienced users tend to have better cognitive performance, while novice users may experience transient impairments, particularly in working memory. However, no randomized clinical trials have systematically evaluated the cognitive effects of ayahuasca in healthy volunteers. Procedures: This double-blind, randomized, placebo-controlled trial evaluated the effects of a single dose of ayahuasca on intelligence and verbal memory in 28 healthy volunteers. Participants were randomized to receive placebo (1.0 mL/kg) or ayahuasca at doses of 0.5, 1.0, or 1.5 mL/kg (n=7 per group). The Wechsler Abbreviated Scale of Intelligence and the Rey Auditory Verbal Learning Test were administered at baseline, 4 hours, and 21 days postadministration.

Results: For intelligence, significant time effects were observed across multiple domains ( P <0.05), but no group × time interactions were detected. For verbal memory, significant time effects were observed for total learning, immediate recall, delayed recall, recognition, and total learning ( P <0.05). A significant group × time interaction was observed only for delayed recall ( P =0.006), with post hoc analysis revealing that the placebo performed better than the 0.5 mL/kg ayahuasca group at 4 hours ( P =0.006). No other interactions reached significance, and no effects persisted at 21 days.

Conclusions: In this preliminary exploratory trial, we found no evidence that a single administration of ayahuasca produced significant or persistent changes in standardized measures of intelligence or verbal memory in healthy volunteers. These findings provide preliminary information regarding short-term tolerability and cognitive performance following controlled administration and may inform future adequately powered trials.

Comparable studies

Other randomized controlled trials on ayahuasca, most cited first.

Study Year Design Participants
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial Patients with treatment-resistant depression 2018 Randomized controlled trial n = 29
Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics Volunteers with prior experience in the use of psychedelics 2003 Double-blind placebo-controlled clinical trial n = 18
Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers Healthy male volunteers with prior experience using ayahuasca 2001 Single-blind crossover placebo-controlled clinical trial n = 6
Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant Male volunteers with prior experience in the use of psychedelics 2006 Randomized controlled trial n = 15
Human brain effects of DMT assessed via EEG-fMRI. Healthy volunteers 2023 Within-subjects, placebo-controlled design n = 20

Citations in the library

Explore topics